Growth for Drug Trials in COVID-free WA

Wrays is delighted to see Linear Clinical Research receiving recognition in the latest edition of Business News. The Nedlands-based drug testing company is about to launch an expansion to nearly double capacity as WA attracts attention from global pharmaceutical companies. Linear’s expansion comes at a time when an estimated 80 per cent of non-COVID drug tests have been cancelled this year, …

Wrays News

Asahi Succeeds in Defending the Allowability of Its Post-Acceptance Claim Amendments in Opposition Proceedings Brought by EMD

In the latest Australian Patent Office decision to consider the allowability of post-acceptance amendments, the patent applicant, Asahi Kasei Medical Co., Ltd. (Asahi), prevailed over the opponent EMD Millipore Corporation (EMD) in defending its amended claims. EMD opposed the grant of Asahi’s patent application for a porous membrane that is useful for removing, by filtration, viruses and other pathogens from …

Wrays Industry Insights, Insights, News

Wrays Promotes Two Life Sciences Attorneys

Wrays is delighted to announce the promotion of two attorneys from our Life Sciences team. Dr Penelope Farbey has been promoted to Special Counsel and Dr Daniel Beck has been promoted to Associate. Dr Penelope Farbey joined Wrays in 2001 and is a molecular microbiology specialist, working closely with small to medium biotechnology, pharmaceutical and agri-biotech firms as well as …

Wrays News

Western Australia’s Impact on World Pharmaceutical Market

For Immediate Release Wrays congratulates their client Dimerix, a Western Australian clinical-stage biopharmaceutical company on the successful stage 2 clinical trial results for their product DMX-200 for the treatment of diabetic kidney disease. The trial results were announced 29 July 2020 and showed positive top-line results for a rare kidney disorder that often leads to end-stage kidney failure. Wrays, one …

Wrays News

Recognition for Wrays, IAM Patent 1000 2020 Rankings

Intellectual Asset Management’s (IAM) Patent 1000 annual patent rankings have just been released. Wrays is pleased to advise that we have been recognised as one of Australia’s leading patents firms delivering exceptional IP services with profound insight in patent matters. The IAM Patent 1000 rankings are regarded as the definitive directory for those seeking to identify world-class, private practice patent …

Wrays News

Richard Baddeley Builds Wrays Engineering & Technology Team

One of Australia’s leading Intellectual Property Law Firms, Wrays, has announced the hiring of Principal, Richard Baddeley. Richard joins Wrays after 31 years at Watermark and after Watermark was subsumed into the listed IPH Group of entities. This high-profile appointment is a coup for Wrays with Richard regarded as ‘a stalwart’ of the Intellectual Property Industry. Richard is the immediate …

Wrays News

Wrays Builds Engineering & Technology Team

Wrays is pleased to announce the appointment of Richard Baddeley who will officially join the firm as a Principal on 1 June 2020. Richard joins Wrays after 31 years at Watermark and after Watermark was subsumed into the listed IPH Group of entities. Richard provides advice on all aspects of intellectual property and has built an impressive track record acting …

Wrays News

Dr Mary Turonek Boosts Wrays’ Chemistry, Resources and Oil & Gas Teams

One of Australia’s leading Intellectual Property Law Firms, Wrays, has announced the hiring of Principal, Dr Mary Turonek. Mary joins the firm from FB Rice. With over 20 years experience Mary adds significant weight to the already-established Perth Chemistry, Resources and Oil and Gas teams. Mary has, in particular, provided IP protection and management for a broad range of Australian …

Wrays News

Staying Connected During COVID-19

As we all continue to navigate this time of change brought about by COVID-19, we wanted to share with you the additional measures that Wrays is taking to ensure the well-being of our employees, clients and our community. Whilst this is clearly a disruptive time, what won’t change is our commitment to our delivery of high-quality intellectual property advice to …

Wrays News

Novel Coronavirus (COVID-19) – A notice to our visitors

As the impact of the novel coronavirus (COVID-19) continues to rise, we feel it’s important to update you on the measures we are taking to ensure the well-being of our employees, clients, guests and the community at large. We are closely monitoring recommendations from WHO, Australian Government Department of Health and other health organizations, and are taking proactive steps to …

Wrays News